Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Cardiotoxicity × Palliative Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 20 Neoplasms 13 Leukemia, Myeloid, Acute 10 Ovarian Neoplasms 6 Lung Neoplasms 6 Hematologic Neoplasms 6 Colorectal Neoplasms 6 Prostatic Neoplasms 5 Neoplasm Metastasis 5 Multiple Myeloma 5 Lymphoma 5 Stomach Neoplasms 4 Leukemia 4 Glioblastoma 4 Fatigue 4 Carcinoma, Non-Small-Cell Lung 4 Vulvar Neoplasms 3 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Pancreatic Neoplasms 3 Myelodysplastic Syndromes 3 Motor Activity 3 Depression 3 Anxiety Disorders 3 Vaginal Neoplasms 2 Sarcoma 2 Rectal Neoplasms 2 Peritoneal Neoplasms 2 Pain 2 Melanoma 2

Interventions

Doxorubicin 13 Exercise 8 Dexrazoxane 7 Cyclophosphamide 7 Razoxane 5 Carvedilol 5 Vincristine 4 Filgrastim 4 Radiotherapy 3 Methotrexate 3 Granulocyte Colony-Stimulating Factor 3 Etoposide 3 Echocardiography 3 Docetaxel 3 Atorvastatin 3 salicylhydroxamic acid 2 sacubitril and valsartan sodium hydrate drug combination 2 empagliflozin 2 Trastuzumab 2 Tablets 2 Prednisone 2 Leucovorin 2 Ivabradine 2 High-Intensity Interval Training 2 Electrocardiography 2 Cisplatin 2 Chemotherapy, Adjuvant 2 Bleomycin 2 Bisoprolol 2 sulforaphane 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04598646 2025-12-03

HIMALAYAS-P

University Health Network, Toronto

Phase NA Completed

Behavior, Heart Failure, Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡